Now Playing

Glaxo Agrees to Pay $3 Billion in Fraud Settlement

British pharmaceutical giant GlaxoSmithKline has agreed to pay $3 billion in civil and criminal fines for promoting two drugs, Paxil and Wellbutrin, for unapproved uses, and failing to report key safety data about the diabetes drug Avandia.

Trouble listening? See our technical support page.